The first study of the immunotherapy drug pembrolizumab as the initial treatment for patients with a rare but aggressive form of skin cancer known as Merkel cell carcinoma reports better responses and longer survival than expected with conventional chemotherapy.
Original Article: The Medical News http://bit.ly/2vtn9T2
>>Hollywood's Exotic Secret For Healthy Weight Loss
0 Response to "Immunotherapy may be better than chemotherapy for Merkel cell carcinoma"
Post a Comment